RAPAd®

    The RAPAd® method of Adenovirus construction, developed by ViraQuest Inc. scientists, has been used by other scientists around the world.

    Request Quote

    Confidentiality

     

    Learn More

    Quality Control

    Plaque forming units guarantee. Non-detectable RCA.

    Learn More

    Turnaround Time

    Sub-cloning to finished particles in about four weeks.

    Learn More

    Dual Expressers

    Multiple transgene expression in a single virus.

    Learn More
Written on 01/01/16

An Ad5[E1-, E2b-]-HER2/neu vector induces immune responses and inhibits HER2/neu expressing tumor progression in Ad5 immune mice.

An Ad5[E1-, E2b-]-HER2/neu vector induces immune responses and inhibits HER2/neu expressing tumor progression in Ad5 immune mice.